Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity
New anticancer ruthenium(II/III) complexes [RuCl<sub>2</sub>(DMSO)<sub>2</sub>(Hapbim)] (<b>1</b>) and [RuCl<sub>3</sub>(DMSO) (Hapbim)] (<b>2</b>) (Hapbim = 2-aminophenyl benzimidazole) have been synthesized and characterized, and their chemotherapeutic potential evaluated. The interaction of the c...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2020-09-01
|
| Sarja: | Molecules |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1420-3049/25/18/4284 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|